Skip to main content
. 2015 Jan 21;6(6):3656–3668. doi: 10.18632/oncotarget.2849

Figure 5. F4 peptide inhibits melanoma cell migration and tumor growth.

Figure 5

(A) Measurement of the wound closure in scratch wound assay, demonstrating that wound closure was significantly delayed when cells were incubated with F4 peptide after 24 h (−53%, p < 0.05), 48 h (−39%, p < 0.05) or 72 h (−36%, p < 0.05) of incubation. Histogram represents the mean ± sd of five experiments; *, p < 0.05, significantly different from controls (Mann and Withney non parametric U-test). (B) F4 peptide inhibits tumor growth in murine melanoma model in vivo. Tumor size was measured at days 7, 9, 11 and 15. Tumor volumes were determined according to v = 1/2 A x B2, where A denotes the largest dimension of the tumor and B represents the smallest dimension. Tumor volume was significantly lower at day 15th (−30%) in F4 peptide-injected mice vs controls. Histogram represents the mean ± sem of ten mice; *, p < 0.05, significantly different from controls (Mann and Withney non parametric U-test).